new_0222_0456|LABP|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0456|LABP|1|Landos Biopharma Inc Total Current Assets (Quarterly) (USD)|Landos Biopharma Inc Cash and Short Term Investments (Quarterly) (USD)|Landos Biopharma Inc Inventories (Quarterly) (USD)|Landos Biopharma Inc Net PP&E (Quarterly) (USD)|Landos Biopharma Inc Goodwill and Intangibles (Quarterly) (USD)|Landos Biopharma Inc Total Liabilities (Quarterly) (USD)|Landos Biopharma Inc Total Current Liabilities (Quarterly) (USD)|Landos Biopharma Inc Total Long Term Liabilities (Quarterly) (USD)|Landos Biopharma Inc Total Deposits (Quarterly) (USD)|Landos Biopharma Inc Book Value (Quarterly) (USD)|Landos Biopharma Inc Retained Earnings (Quarterly) (USD)|Landos Biopharma Inc Treasury Stock (Quarterly) (USD)|Landos Biopharma Inc EV to Revenues|Landos Biopharma Inc EV to Earnings|Landos Biopharma Inc EV to Free Cash Flow|Landos Biopharma Inc EV to Assets (Quarterly)|Landos Biopharma Inc PS Ratio|Landos Biopharma Inc PE Ratio|Landos Biopharma Inc Price to Book Value|Landos Biopharma Inc PEG Ratio|Landos Biopharma Inc Debt to Equity Ratio|Landos Biopharma Inc Dividend Yield|Landos Biopharma Inc Shareholder Yield (TTM)|Landos Biopharma Inc Percent of Shares Outstanding Short|Landos Biopharma Inc Total Receivables (Quarterly) (USD)|Landos Biopharma Inc Total Payables (Quarterly) (USD)|Landos Biopharma Inc Total Capital Stock (Quarterly) (USD)|Landos Biopharma Inc Return on Invested Capital|Landos Biopharma Inc Quality Ratio Score|Landos Biopharma Inc Momentum Score|Landos Biopharma Inc Beta (1Y)|Landos Biopharma Inc Sustainable Growth Rate (TTM)|Landos Biopharma Inc Institutional Investor Ownership Percentage|Landos Biopharma Inc Average Diluted Shares Outstanding (Quarterly)|Landos Biopharma Inc Total Employees (Annual)|Landos Biopharma Inc EPS Diluted (Quarterly) (USD)|Landos Biopharma Inc Shares Outstanding|Landos Biopharma Inc Repurchase of Capital Stock (Quarterly) (USD)|Landos Biopharma Inc Ordinary Shares Number (Quarterly)|Landos Biopharma Inc Payout Ratio|Landos Biopharma Inc Quick Ratio (Quarterly)|Landos Biopharma Inc Normalized Diluted EPS (Quarterly) (USD)|Landos Biopharma Inc Stock Buybacks (Quarterly) (USD)|Landos Biopharma Inc Effective Tax Rate (TTM)|Landos Biopharma Inc Return on Equity|Landos Biopharma Inc Net Income (TTM) (USD)|Landos Biopharma Inc Revenue (TTM) (USD)|Landos Biopharma Inc Dividend Per Share (Quarterly) (USD)|Landos Biopharma Inc Revenue (Quarterly) (USD)|Landos Biopharma Inc Gross Profit (Quarterly) (USD)|Landos Biopharma Inc SG&A Expense (Quarterly) (USD)|Landos Biopharma Inc Pre-Tax Income (Quarterly) (USD)|Landos Biopharma Inc Net Income (Quarterly) (USD)|Landos Biopharma Inc Net Interest Income (Quarterly) (USD)|Landos Biopharma Inc Price (USD)|Landos Biopharma Inc Total Return Price (USD)|Landos Biopharma Inc Enterprise Value (USD)|Landos Biopharma Inc 30-Day Average Daily Volume|Landos Biopharma Inc 1 Year Price Returns (Daily)||
new_0222_0456|LABP|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0456|LABP|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0456|LABP|5|127.8|127.8||127.8||127.8|127.8|127.8||127.8|127.8||||1.4427480916|92|||1.44|||1.4427480916||15.347826087|127.8|127.8|127.8||||||30.6363636364|91.2857142857|92|91.2857142857|31.7777777778||127.8|||91.2857142857|91.25|||91.25|||||91.2857142857|91.2857142857|91.2857142857|91.2857142857|1.44106463878|1.44106463878|1.4427480916|1.44206008584|1.44444444444||
new_0222_0456|LABP|6|5|5||5||5|5|5||5|5||||262|1|||225|||262||23|5|5|5||||||11|7|1|7|9||5|||7|4|||4|||||7|7|7|7|263|263|262|233|9||
new_0222_0456|LABP|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0456|LABP|201912|50.11|49.965||0.359||76.063|3.026|73.037||-25.583|-25.585||||||||||||||0.001|2.048|0.063|||||||32.618||-0.1075|||39.1632|||-0.1097|||||||||0.381|-3.508|-3.508|0.16|||||||
new_0222_0456|LABP|202003||||||||||||||||||||||||||||||||||32.618||-0.1777||||||-0.1709|||||||||1.08|-5.796|-5.796|-0.001|||||||
new_0222_0456|LABP|202006||||||||||||||||||||||||||||||||||32.618||-0.1465||||||-0.1518|||||||||1.365|-4.777|-4.777|0.136|||||||
new_0222_0456|LABP|202009|35.577|35.331||0.348||80.996|7.959|73.037||-44.234|-44.388||||||||||||||0.113|6.652|0.067|||||||32.618|33|-0.2523|||39.1632|||-0.2549||||-22.311|||||1.453|-8.23|-8.23|0.105|||||||
new_0222_0456|LABP|202012|29.888|28.134||0.444||84.347|11.034|73.313||-54.015|-55.729||||-21.5956|||||||||1.5206|0.154|8.606|0.071||||||47.3561|39.1632|33|-0.2896|39.1632||39.1632|||-0.2906||||-30.144|||||1.44|-11.341|-11.341|0.018|13.48|13.48|499.7859||||
new_0222_0456|LABP|202103|109.745|106.358||0.465||9.031|8.819|0.212||101.179|-65.547||||-8.5722||||3.7944|||||2.2767|0.001|8.2|0.399|||||||26.0705||-0.38|39.8667||39.8667|||-0.3807|-90.506|||-34.166|||||2.646|-9.818|-9.818||9.63|9.63|277.5583|211197.4667||11.02|10.98
new_0222_0456|LABP|202106|117.727|115.127||0.564||12.679|12.53|0.149||105.612|-61.45||||-20.048|2.9227|||4.3637|||||1.3305|0.002|10.685|0.399|||||||34.3848||0.12|39.9009||39.9009||9.1883|0.1201||||-25.292|||18||2.596|4.097|4.097|0.179|11.55|11.55|345.7284|50933.0667||10.98|13.28
new_0222_0456|LABP|202109|104.318|102.67||0.78||11.18|11.095|0.085||93.918|-74.054||||-20.1196|4.0756|||6.2265|||||0.7794|0.003|10.114|0.401||||||59.4938|39.9621||-0.32|40.0532||40.0532|||-0.3197||||-29.666|||||3.059|-12.604|-12.604|-0.191|14.6|14.6|482.1067|49814.6667||13.46|7.23
new_0222_0456|LABP|202112|||||||||||||||-3.7752||||2.0564|||||0.369|||||||||59.9013||||||||||||||||||||||4.8|4.8|90.4614|116930.1667|-85.9233|3.43|2.01